Longitudinal change of comprehensive lower urinary tract symptoms and various types of urinary incontinence during robot-assisted radical prostatectomy.


Journal

Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326

Informations de publication

Date de publication:
04 2019
Historique:
received: 05 10 2018
revised: 17 11 2018
accepted: 28 01 2019
entrez: 18 4 2019
pubmed: 18 4 2019
medline: 19 2 2020
Statut: ppublish

Résumé

To clarify longitudinal change of lower urinary tract symptoms (LUTS) and various types of urinary incontinence following robot-assisted radical prostatectomy (RARP) using validated questionnaires. The core lower urinary tract symptom score (CLSS) and the International Consultation on Incontinence Questionnaire (ICIQ)-Short Form (SF) questionnaires were administered to 607 consecutive, treatment-naïve men receiving RARP before and after surgery. The time course of comprehensive LUTS and various types of urinary incontinence, including stress-, urgency-, and urinary incontinence with no obvious reason, were evaluated. Continence recovery rates were compared for the different types of incontinence using Cox hazard regression analysis. After surgery, stress urinary incontinence (SUI) was reported most frequently (32% of cases) as the chief complaint with the most impact on daily life, as assessed by the CLSS questionnaire, followed by urgency urinary incontinence (UUI; 27% of cases). The rates of continence recovery differed among the different types of urinary incontinence, such as after urinating, when dressed, when asleep, when physically active or exercising, when coughing or sneezing, before reaching the toilet, and for no obvious reason. Incontinence for no obvious reason at 1 month after RARP was a strongest prognostic factor of delayed continence recovery (hazard ratio, 0.61; P < 0.0001), whereas patients reporting SUI and UUI gradually regained continence. Further time course on continent recovery after RARP would be more precisely predictable based on the incontinence status at one month postoperatively. Especially, incontinence with no obvious reason would be a significant factor for delayed recovery.

Identifiants

pubmed: 30995359
doi: 10.1002/nau.23952
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1067-1075

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Tetsuya Fujimura (T)

Department of Urology, Jichi Medical University, Yakushiji, Simotsuke-shi, Tochigi, Japan.

Yasuhiko Igawa (Y)

Department of Continence Medicine, Graduate School of Medicine, The University of Tokyo, Japan.

Naoki Aizawa (N)

Department of Continence Medicine, Graduate School of Medicine, The University of Tokyo, Japan.

Aya Niimi (A)

Department of Urology, Graduate School of Medicine, The University of Tokyo, Japan.

Yuta Yamada (Y)

Department of Urology, Graduate School of Medicine, The University of Tokyo, Japan.

Toru Sugihara (T)

Department of Urology, Jichi Medical University, Yakushiji, Simotsuke-shi, Tochigi, Japan.

Jun Kamei (J)

Department of Urology, Jichi Medical University, Yakushiji, Simotsuke-shi, Tochigi, Japan.

Yusuke Sato (Y)

Department of Urology, Graduate School of Medicine, The University of Tokyo, Japan.

Akiko Matsunaga (A)

Department of Rehabilitation, Graduate School of Medicine, The University of Tokyo, Japan.

Mikako Yoshida (M)

Department of Gerontological Nursing/ Wound Care Management, Graduate School of Medicine, The University of Tokyo, Japan.

Yusuke Shinoda (Y)

Department of Rehabilitation, Graduate School of Medicine, The University of Tokyo, Japan.

Hiroshi Fukuhara (H)

Department of Urology, Kyorin University, Tokyo, Japan.

Tohru Nakagawa (T)

Department of Urology, Teikyo University School of Medicine, Tokyo, Japan.

Yukio Homma (Y)

President Japanese Red Cross Medical Center, Tokyo, Japan.

Haruki Kume (H)

Department of Urology, Graduate School of Medicine, The University of Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH